Bentong Yu

Bentong Yu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2025 in Cell Reports Medicine
Verified
Journal Article
Open access
YXYong Xi
Yong Xi
ZZZhijie Zhao
Zhijie Zhao
YZYundong Zhou
Yundong Zhou
CYChengliang Yin
Chengliang Yin
YLYuxin Li
Yuxin Li
WSWeiyu Shen
Weiyu Shen
This study explores the role of efferocytosis in esophageal squamous cell carcinoma (ESCC) using single-cell RNA sequencing and in vitro/in vivo assays. Analyzing 27 samples from 9 patients with ESCC, we identify diverse cell types and significant heterogeneity in the tumor microenvironment, with a focus on efferocytosis. Our findings highlight that macrophages engulf apoptotic tumor cells, thereby impairing immune responses and promoting tumor progression. Notably, TP63 and RAC2 emerge as key regulators of this process, influencing efferocytosis and immune modulation. Functional assays demonstrate that disrupting these pathways alters macrophage efferocytosis and impacts tumor growth in vivo. These results suggest that targeting efferocytosis pathways offers potential therapeutic strategies for ESCC, enhancing antitumor immunity and improving patient outcomes. The study underscores the complex interactions between tumor cells and the immune system, with efferocytosis representing a promising therapeutic target.

6 January 2026 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
ZZZiqi Zhu
Ziqi Zhu
MZMingyang Zhang
Mingyang Zhang
MZMeng Zhang
Meng Zhang
XTXin Tao
Xin Tao
JGJiang Gu
Jiang Gu
BYBentong Yu
Bentong Yu
Toll-like receptor 4 (TLR4), a key pattern recognition receptor in innate immunity, is frequently overexpressed in various malignancies including esophagea

1 July 2026 in Cell Communication and Signaling
Verified
Journal Article
Open access
ZLZhenyu Luo
Zhenyu Luo
HSHaoran Shi
Haoran Shi
YSYingyi Shan
Yingyi Shan
DWDongxiang Wen
Dongxiang Wen
LLLede Lin
Lede Lin
YPYulu Peng
Yulu Peng
Sex bias is pervasive in tumors; however, how sex chromosomes and hormone-responsive signaling shape the tumor microenvironment (TME) remains insufficiently characterized. Considering the critical impact of the TME on tumor progression and response to immunotherapy, a pan-cancer investigation of sex-specific and cancer-context-dependent TME features is warranted. Based on stringent inclusion criteria, we constructed a high-resolution pan-cancer single-cell sequencing atlas by integrating 31 publicly available single-cell RNA-seq datasets, comprising a total of 1,831,436 cells by integrating 468 samples from eight types of non-sex-specific solid tumors (282 males and 186 females). After correcting for batch effects, we identified major and minor cellular subsets. Multiple computational approaches were applied to investigate sex-associated differences in cellular composition, gene expression, pathway activity, malignant cell states and intercellular communication. We systematically compared sex-specific TME features across eight common solid malignancies. Male-biased CD8+ T cell exhaustion emerged as a recurrent but non-uniform feature, with its magnitude varying across cancer types and being modified by tissue-specific contexts. This pattern was associated with androgen-response signature scores and expression-based loss of the Y chromosome (LOY) scores. M2-like macrophage polarization showed a more cancer-type-dependent pattern; although female-biased enrichment was observed in selected malignancies, it did not represent a uniform pan-cancer feature. Expression-based X chromosome inactivation (XCI)/XCI escape-related programs, estrogen-response signature scores and stromal components, including fibroblasts and endothelial cells, were associated with macrophage and immune-regulatory states in specific tumor contexts. Tumor cells of male origin displayed higher genomic instability and more aggressive phenotypes, with androgen-response signatures and LOY contributing to the development of a male biased malignant state. Furthermore, expression-based LOY scores in malignant cells were associated with CD8+ T cell exhaustion based on transcriptomic proxies. Our study uncovers extensive but heterogeneous sex-specific differences in the TME across multiple cancer types. We propose a regulatory framework linking sex chromosomes, hormone-responsive signaling and TME interactions, which is consistent with recurrent male-biased CD8⁺ T cell exhaustion and context-dependent M2-like macrophage polarization. Importantly, the magnitude and, in some cancers, the direction of these sex-biased features are modified by tissue-specific contexts. These findings underscore the need to include sex chromosome and hormone status as essential biological variables in studies of the tumor microenvironment and the design of immunotherapies.

1 June 2026 in Cell Reports
Verified
Journal Article
Open access
QHQifan Hu
Qifan Hu
ZWZuorui Wang
Zuorui Wang
WDWenxin Deng
Wenxin Deng
LWLei Wang
Lei Wang
JCJiayuan Chen
Jiayuan Chen
BYBentong Yu
Bentong Yu
Cuproptosis, a copper-dependent cell death process induced by excessive copper, represents an emerging therapeutic strategy in oncology. However, tumor-specific molecular pathways regulating this process remain poorly defined. Here, we demonstrate that copper levels are elevated in lung adenocarcinoma (LUAD), and LUAD cell lines exhibit increased resistance to cuproptosis. Mechanistically, elevated copper stress promotes the expression of the desuccinylase SIRT5 while reducing global succinylation in LUAD cells. Furthermore, we found that SIRT5 is a critical mediator of cuproptosis through the desuccinylation modification on ferredoxin1 (FDX1) protein at Lys84. This modification triggers TRIM8-mediated ubiquitination, leading to FDX1 proteasomal degradation and enhanced cuproptosis resistance. These results reveal the important role of SIRT5 in LUAD cuproptosis resistance. Notably, combining the SIRT5 inhibitor MC3482 with the cuproptosis inducer Elesclomol-Cu synergistically suppresses tumor growth in vivo, suggesting a promising therapeutic strategy. These findings elucidate mechanisms underlying cuproptosis resistance and propose a novel treatment approach for LUAD.

12 December 2025 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
YXYong Xi
Yong Xi
CXChuan Xu
Chuan Xu
FYFan Ye
Fan Ye
MYMin Yuan
Min Yuan
CYChunlin Ye
Chunlin Ye
BYBentong Yu
Bentong Yu
Accurate delineation of pulmonary nodules in chest computed tomography (CT) is essential for early lung cancer diagnosis and treatment planning. However, voxel-wise segmentation methods often produce fragmented masks and inconsistent topology due to low contrast, anatomical variability, and imaging noise. We propose CoreFormer, a segmentation framework that models nodules through structural core anchoring and geodesic shape decoding. CoreFormer identifies the intrinsic topological core of each nodule and generates continuous boundaries guided by anatomy-aware geodesic paths. It is built upon a Swin Transformer backbone and a dual-branch decoder consisting of a Structural Core Predictor and a Context-Aware Shape Decoder, enhanced by Feature Manifold Regularization for discriminative feature learning. Extensive experiments on four public datasets-LIDC-IDRI, LNDb, Tianchi-Lung (MosMedData), and NSCLC-Radiomics-demonstrate that CoreFormer achieves state-of-the-art boundary accuracy and topological fidelity, offering robust and high-fidelity pulmonary nodule segmentation.

23 September 2026 in Apoptosis
Verified
Journal Article
Closed access
PDF file
ZWZuorui Wang
Zuorui Wang
HWHui Wang
Hui Wang
LWLei Wang
Lei Wang
JCJiayuan Chen
Jiayuan Chen
LJLei Jiang
Lei Jiang
QHQifan Hu
Qifan Hu